Lv1
100 积分 2025-04-11 加入
China’s innovation in translational medicine: rethinking early-stage clinical development
26天前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
1个月前
已完结
Trends in target novelty in oncology R&D
2个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
2个月前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
3个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
6个月前
已完结
Metabolites as agents and targets for cancer immunotherapy
6个月前
已完结
皖公网安备34019202002308
